The next continued petition is PE1662, on improving treatment for patients with Lyme disease and associated tick-borne diseases, which was lodged by Janey Cringean and Lorraine Murray on behalf of Tick-borne Illness Campaign Scotland. The petition calls on the Scottish Government
“to improve testing and treatment for Lyme disease and associated tick-borne diseases by ensuring that medical professionals in Scotland are fully equipped to deal with the complexity of tick-borne infections, addressing the lack of reliability of tests, the full variety of species in Scotland, the presence of ‘persister’ bacteria which are difficult to eradicate, and the complexities caused by the presence of possibly multiple co-infections, and to complement this with a public awareness campaign.”
When the petition was considered previously, in February 2021, the session 5 committee took evidence from the then Minister for Public Health and Sport, Mairi Gougeon, who was supported by Scottish Government officials Dr Gill Hawkins, the senior medical officer for health protection and public health, and Professor Tom Evans, the chief medical officer’s specialty adviser on infectious diseases. During the session, the minister stated that the Scottish Government was
“committed to supporting people with Lyme disease, finding new and better diagnostic and treatment tools, and trying to prevent it in the first place.”—Official Report, Public Petitions Committee, 24 February 2021; c 2.
It was revealed that the Scottish Government would soon be holding a round-table event that would bring together clinicians, patient representatives and public health experts to discuss testing, treatment and raising awareness. The minister confirmed that the Scottish Government was keen to develop an infectious diseases managed clinical network and that consideration of Lyme disease would be included in its workstream. The minister and her officials also agreed that more research was needed to underpin the development of better treatment options, particularly for people with longer-term symptoms.
Do colleagues have any comments or suggestions that they would like to make?

